Impact of Gleason Subtype on Prostate Cancer Detection Using Multiparametric Magnetic Resonance Imaging: Correlation with Final Histopathology

  title={Impact of Gleason Subtype on Prostate Cancer Detection Using Multiparametric Magnetic Resonance Imaging: Correlation with Final Histopathology},
  author={Matthew Truong and Gary M Hollenberg and Eric P. Weinberg and Edward M. Messing and Hiroshi Miyamoto and Thomas Frye},
  journal={The Journal of Urology},

Figures and Tables from this paper

Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer.

Compared with mp MRI-invisible disease, mpMRI-visible tumors are associated with underexpression of cellular organization genes, highlighting the need for biopsy strategies that detect mpMRI -invisible tumors.

Histological differences in cancer cells, stroma, and luminal spaces strongly correlate with in vivo MRI-detectability of prostate cancer

Investigation of plausible histopathological factors that affect the detectability of prostate cancers on multiparametric magnetic resonance imaging found changes in cancer cells, stroma, and luminal spaces could be considered one of the best predictors to clinical, in vivo MRI-detectable of prostate cancer.

Spatial density and diversity of architectural histology in prostate cancer: influence on diffusion weighted magnetic resonance imaging.

Architectural features influence ADC characteristics of MRI, with more complex tumors having lower ADC values regulated by presence and density of specific morphologies.

Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese men

Tumor detectability of csPC with PI-RADS v2 was limited compared with o-mpMRI criteria in Japanese men, and false-negative lesions on o-MPMRI criteria were characterized as small in size, low risk and low cellularity.

Utility of index lesion volume assessed by multiparametric MRI combined with Gleason grade for assessment of lymph node involvement in patients with high-risk prostate cancer.

The combination of biopsy Gleason-grade and mrV may serve as a useful tool to stratify patients according to their risk of nodal metastases in patients with high-risk prostate cancer.



Higher Prostate Cancer Grade Groups Are Detected in Patients Undergoing Multiparametric MRI-targeted Biopsy Compared With Standard Biopsy

MRI/US fusion–guided prostate biopsy is equivalent to the standard-of-care 12-core biopsy in terms of cancer detection and superior in detecting higher grade disease.

Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort

It is argued that Gleason score assignment by current consensus guidelines are not entirely optimized for clinical use, including active surveillance, and suggested that focal poorly formed gland and cribriform patterns should be in separate prognostic groups, as the latter is associated with worse outcome.

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System

The basis for a new grading system was proposed in 2013 by one of the authors and accepted by the World Health Organization for the 2016 edition of Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs.

Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy

It is concluded that CR/IDC+ status in prostate cancer biopsies is associated with a worse disease-specific survival, and men with biopsy CR/ IDC− Gleason score 3+4=7 prostate cancer could be candidates for active surveillance, as these patients have similar survival probabilities to those with Gle Mason score 6.